Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Unity Biotechnology

0.2001
0.0000
Volume:- -
Turnover:- -
Market Cap:3.44M
PE:-0.12
High:0.2001
Open:0.2001
Low:0.2001
Close:0.2001
52wk High:3.10
52wk Low:0.2001
Shares:17.21M
Float Shares:15.88M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6323
EPS(LYR):-1.5445
ROE:-231.27%
ROA:-38.89%
PB:-16.80
PE(LYR):-0.13

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
Unity Biotechnology
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Website:
http://www.unitybiotechnology.com
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2048, a Tie2/VEGF bispecific; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.